Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Objectives
- Role of quality control in cell processes
- Eukaryotic cells are highly compartmentalized
- The ER environment
- ER protein folding and quality control
- Protein folding: ribonuclease A
- Molecular chaperones
- Protein disulfide isomerase (PDI)
- PDIs which are present in the lumen
- Prolyl cis-trans isomerase (PPI)
- Molecular chaperones and foldases in the ER
- N-glycosylation
- N-glycan precursor synthesis
- Glc3Man9GlcNAc2 glycan trimming in the ER
- Calnexin: a lectin type chaperone
- Calnexin transiently interacts with glycoproteins
- The calnexin cycle (1)
- Calnexin binds monoglucosylated glycoproteins
- Binding of Glc1Man9 RNaseB intermediates
- Calnexin lumenal domain
- The calnexin cycle (2)
- ERp57
- RNase B refolding, catalyzed by ERp57 or PDI (1)
- RNase B refolding, catalyzed by ERp57 or PDI (2)
- Mapping the ERp57 binding site on calnexin
- ERp57 structure and the calnexin binding site
- PPIs also interact with calnexin/calreticulin
- PDI-bb' domains can bind hydrophobic peptides
- UDP-glucose glucosyl glycoprotein transferase
- Man9GlcNAc2 glycoproteins from yeast DT111
- Glucosylation of Man9GlcNAc2 glycopeptides
- Rank order of peptides glucosylated by UGGT
- Structure of beta-glucanase
- UGGT substrates can be mutant but active
- The calnexin cycle (3)
- Disposal of misfolded glycoproteins by ERAD
- The fate of glycoproteins
- The ER quality control apparatus
- ER quality control
- Concluding words
Topics Covered
- The endoplasmic reticulum
- Protein folding
- Molecular chaperones
- N-glycosylation
- Lectin-type chaperones calnexin and calreticulin
- Link between protein folding and glycosylation
- ER quality control
Talk Citation
Thomas, D.Y. (2012, February 2). The recognition of misfolded glycoproteins in the endoplasmic reticulum [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/WLUG6188.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. David Y. Thomas has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Hide